Modelos de dados selecionados

Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.

26 Resultados da pesquisa.
Relevância Avaliação Novos primeiro Antigos primeiro

Intraocular Pressure Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4170g - Intraocular Pressure Screening

- 21/03/2018 - 1 Formulário, 1 Grupo de itens, 9 Elementos de dados, 1 Idioma
Grupo de itens: Intraocular Pressure
Study part: Intraocular Pressure Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.

Intraocular Pressure Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4168g - Intraocular Pressure Screening

- 21/03/2018 - 1 Formulário, 1 Grupo de itens, 9 Elementos de dados, 1 Idioma
Grupo de itens: Intraocular Pressure
Study part: Intraocular Pressure Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.

Intraocular Pressure Screening Ranibizumab Macular Edema Secondary To Branch Retinal Vein Occlusion FVF4165g - Intraocular Pressure Screening

- 18/03/2018 - 1 Formulário, 1 Grupo de itens, 9 Elementos de dados, 1 Idioma
Grupo de itens: Intraocular Pressure
Study part: Intraocular Pressure Screening. A Phase III, Multicenter, Randomized, Sham Injection-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection Compared With Sham In Subjects with Macular Edema Secondary To Branch Retinal Vein Occlusion.

Intraocular Pressure Screening Ranibizumab Age-Related Macular Degeneration FVF3192g - Intraocular Pressure Screening

- 22/02/2018 - 1 Formulário, 1 Grupo de itens, 9 Elementos de dados, 1 Idioma
Grupo de itens: Intraocular Pressure
Study part: Intraocular Pressure Screening. A Phase IIIb, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of Ranibizumab In Subjects With Subfoveal Choroidal Neovascular (CNV) With Or Without Classic CNV Secondary To Age-Related Macular Degeneration.

Intraocular Pressure Month 3 rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2598g - Intraocular Pressure Month 3

- 18/02/2018 - 1 Formulário, 2 Grupos de itens, 15 Elementos de dados, 1 Idioma
Grupos de itens: Intraocular Pressure Pre- dose, Intraocular Pressure Post- dose
Study part: Intraocular Pressure Month 3. A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration.

Intraocular Pressure Day 0 rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2598g - Intraocular Pressure Day 0

- 18/02/2018 - 1 Formulário, 2 Grupos de itens, 15 Elementos de dados, 1 Idioma
Grupos de itens: Intraocular Pressure Pre- dose, Intraocular Pressure Post- dose
Study part: Intraocular Pressure Day 0. A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration.

Intraocular Pressure Screening rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2598g - Intraocular Pressure Screening

- 18/02/2018 - 1 Formulário, 1 Grupo de itens, 9 Elementos de dados, 1 Idioma
Grupo de itens: Intraocular Pressure
Study part: Intraocular Pressure Screening. A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration.

Intraocular Pressure Month 12 rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2587g - Intraocular Pressure Month 12

- 04/02/2018 - 1 Formulário, 2 Grupos de itens, 15 Elementos de dados, 1 Idioma
Grupos de itens: Intraocular Pressure Pre- dose, Intraocular Pressure Post- dose
Study part: Intraocular Pressure Month 12. A Phase III, Multicenter, Randomized, Double-Masked, Active Treatment-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) Compared With Verteporfin (Visudyne®) Photodynamic Therapy In Subjects With Predominantly Classic Subfoveal Neovascular Age-Related Macular Degeneration.

Intraocular Pressure Month 11 rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2587g - Intraocular Pressure Month 11

- 24/01/2018 - 1 Formulário, 2 Grupos de itens, 15 Elementos de dados, 1 Idioma
Grupos de itens: Intraocular Pressure Pre- dose, Intraocular Pressure Post- dose
Study part: Intraocular Pressure Month 11. A Phase III, Multicenter, Randomized, Double-Masked, Active Treatment-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) Compared With Verteporfin (Visudyne®) Photodynamic Therapy In Subjects With Predominantly Classic Subfoveal Neovascular Age-Related Macular Degeneration.

Intraocular Pressure Month 10 rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2587g - Intraocular Pressure Month 10

- 24/01/2018 - 1 Formulário, 2 Grupos de itens, 15 Elementos de dados, 1 Idioma
Grupos de itens: Intraocular Pressure Pre- dose, Intraocular Pressure Post- dose
Study part: Intraocular Pressure Month 10. A Phase III, Multicenter, Randomized, Double-Masked, Active Treatment-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) Compared With Verteporfin (Visudyne®) Photodynamic Therapy In Subjects With Predominantly Classic Subfoveal Neovascular Age-Related Macular Degeneration.

Intraocular Pressure Month 9 rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2587g - Intraocular Pressure Month 9

- 24/01/2018 - 1 Formulário, 2 Grupos de itens, 15 Elementos de dados, 1 Idioma
Grupos de itens: Intraocular Pressure Pre- dose, Intraocular Pressure Post- dose
Study part: Intraocular Pressure Month 9. A Phase III, Multicenter, Randomized, Double-Masked, Active Treatment-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) Compared With Verteporfin (Visudyne®) Photodynamic Therapy In Subjects With Predominantly Classic Subfoveal Neovascular Age-Related Macular Degeneration.

Intraocular Pressure Month 8 rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2587g - Intraocular Pressure Month 8

- 23/01/2018 - 1 Formulário, 2 Grupos de itens, 15 Elementos de dados, 1 Idioma
Grupos de itens: Intraocular Pressure Pre- dose, Intraocular Pressure Post- dose
Study part: Intraocular Pressure Month 8. A Phase III, Multicenter, Randomized, Double-Masked, Active Treatment-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) Compared With Verteporfin (Visudyne®) Photodynamic Therapy In Subjects With Predominantly Classic Subfoveal Neovascular Age-Related Macular Degeneration.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial